| 25B-NBOMe | Section 3.4 |
| 25C-NBOMe | Section 3.4 |
| 25I-NBOMe | Section 3.4 |
| 2C-B | Section 3.4 |
| 2C-B | Section 3.4 |
| 2C-I | Section 3.4 |
| 2C-I | Section 3.4 |
| 2C-T-7 | Section 3.4 |
| 2C-T-7 | Section 4 |
| 2-DPMP | Section 3.4 |
| 3-MMC | Section 7 |
| 4-APB | Section 3.4 |
| 4-MMC | Section 3.2 |
| 4-OH-DiPT | Section 3.4 |
| 5-APB | Section 3.4 |
| 5-MeO-DMT | Section 3.1.2 |
| 5-MeO-DMT | Section 3.1.2 |
| 5-OH-DMT | Section 3.1.2 |
| 6-APB | Section 3.4 |
| AB-CHMINACA | Section 3.2 |
| ADB-FUBINACA | Section 3.2 |
| AM-356 | Section 3.2 |
| AM-4030 | Section 3.2 |
| Atropine | Section Tropane Alkaloids |
| Bufotenin | Section 3.1.2 |
| BZP | Section 3.4 |
| Cathinone | Section 1, Section 3.3, Section 6, Section 7 and Section 8 |
| Cocaine | Section 1, Section 3.2, Section 3.4 and Section 7; Section Indole Alkaloids |
| CP-47947 | Section 3.2 |
| D2PM | Section 3.4 |
| D2PM | Section 3.4 |
| DiTP | Section 3.4 |
| DMT | Section 3.1.2 and Section 6 |
| DOB | Section 3.4 |
| DOI | Section 3.4 |
| Ephedrine | Section Pseudoalkaloids; Section 5 |
| Ephedrone | Section 3.2 |
| HU-210 | Section 3.2 |
| Hyoscyamine | Section Tropane Alkaloids |
| K2 | Section 1 and Section 3.2 |
| Kratom | Section 1; Section Indole Alkaloids |
| LSA | Section Ergoline Alkaloids |
| LSD | Section Ergoline Alkaloids; Section 3.1.2 |
| mCPP | Section 3.4 |
| MDMA | Section 1, Section 3.2 and Section 3.4 |
| MDPV | Section 3.3 |
| Mephedrone | Section 3.3 |
| Methamphetamine | Section 3.3; Section 3.4 |
| Methcathinone | Section 3.3 |
| NBOMe | Section 3.4 |
| PMMA | Section 3.4 |
| Scopolamine | Section Tropane Alkaloids |
| Spice | Section 1, Section 3.2 and Section 4.2 |
| TFMPP | Section 3.4 |
| THC | Section 3.2 |
| THJ-018 | Section 3.2 |
| THJ-2201 | Section 3.2 |
| βk-MBDB | Section 3.3 |
| βk-MDMA | Section 3.2 |